COGT
Price
$4.37
Change
+$0.10 (+2.34%)
Updated
Apr 17 closing price
Capitalization
497.52M
23 days until earnings call
PMVP
Price
$1.02
Change
+$0.02 (+2.00%)
Updated
Apr 17 closing price
Capitalization
52.97M
18 days until earnings call
Ad is loading...

COGT vs PMVP

Header iconCOGT vs PMVP Comparison
Open Charts COGT vs PMVPBanner chart's image
Cogent Biosciences
Price$4.37
Change+$0.10 (+2.34%)
Volume$1.16M
Capitalization497.52M
PMV Pharmaceuticals
Price$1.02
Change+$0.02 (+2.00%)
Volume$89.4K
Capitalization52.97M
COGT vs PMVP Comparison Chart
Loading...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PMVP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COGT vs. PMVP commentary
Apr 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a Hold and PMVP is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 20, 2025
Stock price -- (COGT: $4.37 vs. PMVP: $1.02)
Brand notoriety: COGT and PMVP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COGT: 84% vs. PMVP: 72%
Market capitalization -- COGT: $497.52M vs. PMVP: $52.97M
COGT [@Biotechnology] is valued at $497.52M. PMVP’s [@Biotechnology] market capitalization is $52.97M. The market cap for tickers in the [@Biotechnology] industry ranges from $282.79B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COGT’s FA Score shows that 0 FA rating(s) are green whilePMVP’s FA Score has 0 green FA rating(s).

  • COGT’s FA Score: 0 green, 5 red.
  • PMVP’s FA Score: 0 green, 5 red.
According to our system of comparison, PMVP is a better buy in the long-term than COGT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COGT’s TA Score shows that 4 TA indicator(s) are bullish while PMVP’s TA Score has 5 bullish TA indicator(s).

  • COGT’s TA Score: 4 bullish, 4 bearish.
  • PMVP’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, PMVP is a better buy in the short-term than COGT.

Price Growth

COGT (@Biotechnology) experienced а +8.71% price change this week, while PMVP (@Biotechnology) price change was +17.24% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.03%. For the same industry, the average monthly price growth was -13.25%, and the average quarterly price growth was -24.49%.

Reported Earning Dates

COGT is expected to report earnings on Aug 12, 2025.

PMVP is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+7.03% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COGT($498M) has a higher market cap than PMVP($53M). PMVP YTD gains are higher at: -32.450 vs. COGT (-43.974). PMVP has higher annual earnings (EBITDA): -84.3M vs. COGT (-271.59M). COGT has more cash in the bank: 287M vs. PMVP (169M). PMVP has less debt than COGT: PMVP (1.19M) vs COGT (17.5M). COGT (0) and PMVP (0) have equivalent revenues.
COGTPMVPCOGT / PMVP
Capitalization498M53M940%
EBITDA-271.59M-84.3M322%
Gain YTD-43.974-32.450136%
P/E RatioN/AN/A-
Revenue00-
Total Cash287M169M170%
Total Debt17.5M1.19M1,471%
FUNDAMENTALS RATINGS
COGT: Fundamental Ratings
COGT
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
77
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
95
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
COGTPMVP
RSI
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
85%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
83%
Bullish Trend 4 days ago
73%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
72%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
87%
Advances
ODDS (%)
Bullish Trend 6 days ago
83%
Bullish Trend 6 days ago
76%
Declines
ODDS (%)
Bearish Trend 13 days ago
83%
Bearish Trend 13 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
71%
Aroon
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
85%
View a ticker or compare two or three
Ad is loading...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PMVP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME26.780.53
+2.02%
GameStop Corp
AAPL196.982.71
+1.39%
Apple
BTC.X85063.414000612.609400
+0.73%
Bitcoin cryptocurrency
SPY525.66N/A
N/A
SPDR® S&P 500® ETF
TSLA241.37-0.18
-0.07%
Tesla

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with HOFBF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then HOFBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
+2.34%
HOFBF - COGT
63%
Loosely correlated
N/A
TNFA - COGT
55%
Loosely correlated
-25.44%
ARWR - COGT
52%
Loosely correlated
-12.67%
ETNB - COGT
50%
Loosely correlated
+2.89%
RCKT - COGT
48%
Loosely correlated
+2.93%
More

PMVP and

Correlation & Price change

A.I.dvisor indicates that over the last year, PMVP has been loosely correlated with RCKT. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if PMVP jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PMVP
1D Price
Change %
PMVP100%
+2.00%
RCKT - PMVP
40%
Loosely correlated
+2.93%
CLLS - PMVP
39%
Loosely correlated
+1.40%
SEER - PMVP
37%
Loosely correlated
-0.51%
COGT - PMVP
36%
Loosely correlated
+2.34%
PLRX - PMVP
36%
Loosely correlated
+1.39%
More